{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Aff3 grid.417728.f0000000417568807Unit of Clinical and Experimental ImmunologyHumanitas Clinical and Research Center Rozzano Milan Italy",
    "Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy",
    "1Pear Bio, London, UK",
    "Cytospire Therapeutics, London, UK"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Domenico Mavilio"
    },
    {
      "affs": [
        1
      ],
      "name": "Valentina Cazzetta"
    },
    {
      "affs": [
        1
      ],
      "name": "Joanna Mikulak"
    },
    {
      "affs": [
        2
      ],
      "name": "Roseanna Hare"
    },
    {
      "affs": [
        3
      ],
      "name": "James W Legg"
    },
    {
      "affs": [
        3
      ],
      "name": "Mark Uden"
    },
    {
      "affs": [
        3
      ],
      "name": "Robert Good"
    },
    {
      "affs": [
        3
      ],
      "name": "Julie Hoong"
    },
    {
      "affs": [
        3
      ],
      "name": "Aleksandra Laskowska"
    },
    {
      "affs": [
        3
      ],
      "name": "Fevzi Demircioglu"
    },
    {
      "affs": [
        3
      ],
      "name": "Shauna Corcoran"
    },
    {
      "affs": [
        3
      ],
      "name": "Luke Cave"
    },
    {
      "affs": [
        3
      ],
      "name": "Carlotta Cattolico"
    },
    {
      "affs": [
        3
      ],
      "name": "Leia Griffin"
    },
    {
      "affs": [
        3
      ],
      "name": "Natalie Mount"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/3bvb7b941w6qy.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0822",
  "fulltext_url": null,
  "id": "3bvb7b941w6qy",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0822",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225198625",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A934.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/3bvb7b941w6qy.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:20:56Z",
      "native_id": "063d55c2de48437dabe70b3eabc60e5a",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0822"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "822 CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors",
  "title_text": "822 CYT X300, a novel EGFR x pan-gamma delta T cell engager for the treatment of solid tumors",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:24Z",
  "url": "https://research.draconitic.com/paper/3bvb7b941w6qy",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}